Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jul 7, 2017; 23(25): 4559-4568
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4559
Figure 3
Figure 3 Rosuvastatin reduced the levels of dextran sodium sulphate-induced serum inflammatory cytokines. Analysis of multiplex ELISA showed that the levels of serum IL-2, IL-4, IL-5, IL-6, IL-12 and IL-17, and G-CSF were markedly decreased in the rosuvastatin-treated group. Data are expressed as mean ± SE. DSS: Dextran sodium sulphate; Ro: Rosuvastatin.